SI1216047T1 - Kombinacija loteprednola in agonistov beta2-adrenoceptorja in njena uporaba za zdravljenje bronhialne astme - Google Patents

Kombinacija loteprednola in agonistov beta2-adrenoceptorja in njena uporaba za zdravljenje bronhialne astme

Info

Publication number
SI1216047T1
SI1216047T1 SI200030769T SI200030769T SI1216047T1 SI 1216047 T1 SI1216047 T1 SI 1216047T1 SI 200030769 T SI200030769 T SI 200030769T SI 200030769 T SI200030769 T SI 200030769T SI 1216047 T1 SI1216047 T1 SI 1216047T1
Authority
SI
Slovenia
Prior art keywords
loteprednol
beta2
inhalation
treatment
combination
Prior art date
Application number
SI200030769T
Other languages
English (en)
Inventor
Istvan Szelenyi
Hildegard Poppe
Sabine Heer
Juergen Engel
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of SI1216047T1 publication Critical patent/SI1216047T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SI200030769T 1999-09-30 2000-09-26 Kombinacija loteprednola in agonistov beta2-adrenoceptorja in njena uporaba za zdravljenje bronhialne astme SI1216047T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19947235A DE19947235A1 (de) 1999-09-30 1999-09-30 Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
EP00969304A EP1216047B1 (de) 1999-09-30 2000-09-26 Kombination von loteprednol und beta2-adrenozeptor-agonisten und ihre verwendung durch inhalation zur behandlung von asthma bronchiale
PCT/EP2000/009392 WO2001022956A2 (de) 1999-09-30 2000-09-26 NEUE KOMBINATION VON LOTEPREDNOL UND β2-ADRENOZEPTOR-AGONISTEN

Publications (1)

Publication Number Publication Date
SI1216047T1 true SI1216047T1 (sl) 2006-02-28

Family

ID=7924101

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030769T SI1216047T1 (sl) 1999-09-30 2000-09-26 Kombinacija loteprednola in agonistov beta2-adrenoceptorja in njena uporaba za zdravljenje bronhialne astme

Country Status (20)

Country Link
US (1) US7521438B1 (sl)
EP (1) EP1216047B1 (sl)
JP (1) JP5068912B2 (sl)
AR (1) AR025924A1 (sl)
AT (1) ATE306271T1 (sl)
AU (1) AU7907400A (sl)
BR (1) BR0014374B1 (sl)
CA (1) CA2389111C (sl)
CY (1) CY1105548T1 (sl)
CZ (1) CZ296396B6 (sl)
DE (2) DE19947235A1 (sl)
DK (1) DK1216047T3 (sl)
EE (1) EE05050B1 (sl)
ES (1) ES2248131T3 (sl)
HU (1) HUP0202753A3 (sl)
MX (1) MXPA02003329A (sl)
PL (1) PL196729B1 (sl)
SI (1) SI1216047T1 (sl)
TW (1) TWI253930B (sl)
WO (1) WO2001022956A2 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US20090246281A1 (en) * 2003-11-03 2009-10-01 Norton Healthcare Ltd. Soft steroid compositions for use in dry powder inhalers
EP2221048A1 (en) * 2009-02-18 2010-08-25 Siegfried Generics International AG Pharmaceutical composition for inhalation
US9238144B2 (en) * 2013-03-14 2016-01-19 Neuropace, Inc. Optimizing data retrieval from an active implantable medical device
WO2022016150A1 (en) * 2020-07-17 2022-01-20 Ross Peter M Methods for the treatment of cytokine release syndromes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB416950A (en) * 1933-07-28 1934-09-25 Ambrose Heal An improved support member for beds, settees, wardrobes and other articles of furniture
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
ZA814440B (en) * 1980-07-10 1982-10-27 Otsuka Pharma Co Ltd Soft steroids having anti-inflammatory activity
TW503113B (en) * 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
DK1014943T3 (da) * 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
US5830490A (en) 1997-04-04 1998-11-03 Weinstein; Robert E. Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation

Also Published As

Publication number Publication date
BR0014374B1 (pt) 2012-12-25
CY1105548T1 (el) 2010-07-28
CA2389111A1 (en) 2001-04-05
US7521438B1 (en) 2009-04-21
PL353487A1 (en) 2003-11-17
EE200200163A (et) 2003-04-15
EE05050B1 (et) 2008-08-15
WO2001022956A3 (de) 2001-10-11
WO2001022956A2 (de) 2001-04-05
AU7907400A (en) 2001-04-30
AR025924A1 (es) 2002-12-18
DE19947235A1 (de) 2001-04-05
MXPA02003329A (es) 2004-09-10
EP1216047A2 (de) 2002-06-26
EP1216047B1 (de) 2005-10-12
JP2003510276A (ja) 2003-03-18
DK1216047T3 (da) 2006-02-13
DE50011340D1 (de) 2006-02-23
HUP0202753A2 (hu) 2002-12-28
CZ20021095A3 (cs) 2002-08-14
PL196729B1 (pl) 2008-01-31
ATE306271T1 (de) 2005-10-15
CZ296396B6 (cs) 2006-03-15
JP5068912B2 (ja) 2012-11-07
TWI253930B (en) 2006-05-01
CA2389111C (en) 2009-04-14
ES2248131T3 (es) 2006-03-16
BR0014374A (pt) 2002-06-25
HUP0202753A3 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
PT2042168E (pt) Formulação de inalação compreendendo derivados de fenetanolamina para o tratamento de doenças respiratórias
ZA200404144B (en) Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms.
SI1757606T1 (sl) Ksantinski derivati za uporabo kot zdravila kot tudi postopek za njihovo pripravo
IL150027A0 (en) Carbon dioxide enhancement of inhalation therapy
PL366636A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
PT1530466E (pt) Utilização de nintedanib para o tratamento de fibrose pulmonar
AU2002305236A8 (en) Composition, formulations and kits for treatment of respiratory and lung disease with anti-sense oligonucleotides and a bronchodilating agent
EP1516049A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF LUNG CANCER
AU6083899A (en) Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
EP1478438A4 (en) TECHNIQUES AND COMPOSITIONS FOR THE TREATMENT OF ASTHMA AND RELATED DISORDERS
PL358375A1 (en) Medicaments for treating respiratory disorders comprising formoterol and fluticasone
GB0004531D0 (en) The treatment of respiratory diseases
AU2001293891A1 (en) New combination for the treatment of asthma
SI1216047T1 (sl) Kombinacija loteprednola in agonistov beta2-adrenoceptorja in njena uporaba za zdravljenje bronhialne astme
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
AU5262200A (en) Arrangement in ventilatory treatment of the lungs
AU2001249262A1 (en) Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2002231283A1 (en) Use of p38 inhibitors for the treatment of smoke inhalation
IL149170A0 (en) Use of nitric oxide for the treatment of airway constriction
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
HU9802379D0 (en) Inhaler for treatment of asthma
HK1070900A1 (en) Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds